| 产品名称 | ReVacc Scientific M17T52 | Anti-Lassa Virus GP Monoclonal Neutralizing Antibody |
|---|---|
| 目录号 | M17T52 |
| 别名 | Anti-Lassa Virus GP Monoclonal Neutralizing Antibody |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| M17T52 | 100 μg; 500 μg | 咨询 | 咨询 |
ReVacc Scientific M17T52 | Anti-Lassa Virus GP Monoclonal Neutralizing Antibody
品名：Anti-Lassa Virus GP Monoclonal Neutralizing Antibody
货号：M17T52
品牌：ReVacc Scientific
规格：100 μg; 500 μg
产品描述
| Target | Lassa | Epitope | - |
| Clonality and isotype | Monoclonal antibody human IgG1 | Conjugate | Unconjugated |
| Description | This antibody binds to glycoprotein (GP) of Lassa virus (LASV), and shows the potent neutralizing activity against LASV VSV-pseudovirus (strain of Josiah) (Catalog # M85H4). | ||
| Applications | IF, WB, ELISA, IHC, IP, Neutralization control et al. For Western blotting, the suggested use of this reagent is 0.1 - 0.5 μg/ml. For ELISA, the suggested use is 1-10 μg/ml. For immunocytochemistry, a concentration range of 0.1 - 0.5 μg/ml is recommended. For neutralization assay, the suggested concentration is 0.5-10 μg/ml. It is recommended that the reagent should be titrated for optimal performance by the user. | ||
| Specificity | Lassa virus (LASV) | ||
| Form | Liquid in PBS, pH7.2, without preservatives | ||
| Purification | Cell culture supernatant followed by filtration and Protein A purification | ||
| Storage | Shipped at ambient temperature. Stored at 4 °C. | ||
